Adicet Bio, Inc. (NASDAQ:ACET) Receives $14.50 Consensus Price Target from Analysts
Shares of Adicet Bio, Inc. (NASDAQ:ACET – Get Free Report) have earned an average rating of “Moderate Buy” from the seven research firms that are presently covering the stock, Marketbeat reports. Three investment analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average twelve-month […]
More Stories
State Department Urges Vigilance for Americans Overseas Amid Iran Conflict
By Bill Pan The U.S. Department of State is urging Americans worldwide, particularly those in the Middle East, to exercise...
Trump Admin Seeks Months-Long Pause on Tariff Refunds
By Bill Pan The Trump administration says it needs months of additional time to weigh its steps, as a wave...
Iran Targets US Bases in Middle East in Retaliatory Attacks: What We Know So Far
By T.J. Muscaro Iran’s Revolutionary Guard said it has launched retaliatory attacks against multiple nearby U.S. military bases on Feb....
US, Israel Strike Iran
By Sam Dorman President Donald Trump released a video on Feb. 28 stating that the United States had begun “major...
Subaru Recalls Nearly 70,000 Vehicles for Fuel Leak Risk, Issues ‘Park Outside’ Warning
By Mary Prenon Subaru and Kia America have both issued recalls involving thousands of vehicles with elevated risks for accidents...
Melania Trump Set to Make History by Chairing UN Security Council Meeting
By Evgenia Filimianova U.S. First Lady Melania Trump will make history on March 2 when she presides over a U.N....